• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Amazon’s PillPack to Integrate with BCBS Massachusetts’ Member App

Share:

December 17, 2019

Amazon’s PillPack has struck a deal with Blue Cross Blue Shield of Massachusetts that integrates the former’s digital pharmacy platform into the payer’s MyBlue member app.

As part of the agreement Blue Cross members will have the option to switch their prescriptions over to PillPack directly from the MyBlue app without having to reenter their insurance details or medication list.

Members will also have access to PillPack’s services, which include pre-sorted medication shipped directly to a patient’s house. It will also include access to an online pharmacist for phone, email or online chat. The service also checks to make sure there are no adverse medication interactions and can coordinate with clinicians to avoid gaps in prescriptions.

WHY IT MATTERS

It’s been about 18 months since Amazon acquired the Boston-based startup PillPack for a whopping $753 million. Since then the tech giant has been subtly making moves. In April it kicked off its PillPack marketing campaign with an email to its Prime users. More recently the digital pharmacy rebranded from “PillPack, an Amazon company” to “PillPack by Amazon Pharmacy.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Currently, it is in-network with all major pharmacy benefit managers, including CVS Caremark, Express Scripts, Optum Rx, Prime Therapeutics, Humana Pharmacy Solutions, Cigna, Aetna, MedImpact, EnvisionRx and CastiaRX.

But it hasn’t been all smooth sailing since the acquisition. Over the summer reports emerged that Amazon was contemplating a lawsuit against e-prescribing company Surescripts, after the former took action to prevent PillPack from accessing its patient information.

THE LARGER TREND

PillPack is not the only virtual pharmacy on the market. Recently Capsule, a New York City-based startup, scored $200 million to expand its hand-delivered same-day medication drop off services.

Also coming into the space is NowRx, an online pharmacy specializing in same-day, same-hour prescription deliveries. In October, the company announced a $7 million Series A raise.

ON THE RECORD

“By using the MyBlue app or website to switch to PillPack, members who take multiple medications won’t need to stand in line at a pharmacy, spend their time sorting pills or worry about missing a refill,” Katie Catlender, VP of customer experience at Blue Cross, said in a statement. “We hope this integration with PillPack will make it easy for our members to have a convenient way to manage their medications so they can get back to focusing on what’s most important to them.”

Source: MobiHealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • North Carolina Taps Phreesia to Help with Social Determinants of HealthNorth Carolina Taps Phreesia to Help with Social Determinants of Health
  • Top 6 Digital Transformation Trends In Healthcare For 2019Top 6 Digital Transformation Trends In Healthcare For 2019
  • HDL Therapeutics Inc Plans to Become Publicly Traded Via a Business Combination with $225 Million Swiftmerge (NASDAQ: IVCP) with Goal to Transform Cardiovascular Disease TreatmentHDL Therapeutics Inc Plans to Become Publicly Traded Via a Business Combination with $225 Million Swiftmerge (NASDAQ: IVCP) with Goal to Transform Cardiovascular Disease Treatment
  • Walmart and BetterUp Team up on Caregiver Support ToolWalmart and BetterUp Team up on Caregiver Support Tool
  • Paige Lands Additional $20M for AI-Native Digital Pathology EcosystemPaige Lands Additional $20M for AI-Native Digital Pathology Ecosystem
  • Kala Pharmaceuticals Acquires Combangio, Expanding Its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and Other Rare Ocular Surface DiseasesKala Pharmaceuticals Acquires Combangio, Expanding Its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and Other Rare Ocular Surface Diseases
  • Genalyte and Sonora Quest Laboratories Partner to Provide Predictive Analytics for Cigna’s Medicare Advantage PlanGenalyte and Sonora Quest Laboratories Partner to Provide Predictive Analytics for Cigna’s Medicare Advantage Plan
  • AdaptHealth Expands Into Diabetes Segment With Accretive Acquisition of Leading Distributor Solara Medical SuppliesAdaptHealth Expands Into Diabetes Segment With Accretive Acquisition of Leading Distributor Solara Medical Supplies

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications